Abstract:Key Points A large fraction of point mutations that cause genetic diseases affect splicing efficiency and/or accuracy. Most of these mutations directly affect the canonical consensus sequences that define exon–intron boundaries, and are therefore correctly identified as 'splicing mutations'. Information that is present in the coding regions of genes also contributes to the correct identification of exon–intron boundaries. For example, exonic splicing enhancer (ESE) and silencer (ESS) elements are very prevalent and might be present in most, if not all, constitutive and alternative exons. ESEs are recognized by a class of splicing factors, the SR proteins, that promote splicing by recruiting spliceosomal components to the correct splice sites and/or by antagonizing the action of nearby silencers. Several classes of ESEs, which are recognized by different SR proteins, have been identified, and computational tools are being developed to predict the location, specificity and efficiency of putative ESEs. Because ESEs are embedded in protein-coding sequences, some nonsense, missense and translationally silent point mutations have actually been misclassified. Those mutations that inactivate an ESE can result in partial or complete exon skipping, and can therefore markedly affect the structure or amounts of the expressed protein product. An increasing proportion of point mutations are being reported to affect pre-mRNA splicing. Although reading-frame-dependent mechanisms have been proposed to account for nonsense-associated altered splicing (NAS), in most cases the disruption of ESEs or of RNA secondary structures that are required for proper splicing seems to be the mechanism that leads to exon skipping, regardless of the type of point mutation. Some coding single-nucleotide polymorphisms (cSNPs) can be expected likewise to disrupt elements that are involved in splicing and to exert a subtle effect on splice-site selection, thereby contributing to phenotypic variability, to the variable penetrance of mutations elsewhere in the gene and to cell-type-specific differences in gene expression. The effects of point mutations should be routinely analysed at the mRNA level before drawing conclusions about the importance of the affected amino acid, as their correct classification in terms of the actual mechanism of gene inactivation is essential for understanding structure–function relationships in the corresponding protein, for assessing the phenotypic risk in individuals with familial disease predispositions and for devising new therapies.

RNA splicing is a primary link between genetic variation and disease

The human splicing code reveals new insights into the genetic determinants of disease

RNA mis-splicing in disease

Prioritizing Single-Nucleotide Variations That Potentially Regulate Alternative Splicing.

Aberrant RNA Splicing As the Molecular Basis of Some Pathogenic Variants.

Splicedisease Database: Linking Rna Splicing and Disease

The impact of genetically controlled splicing on exon inclusion and protein structure

Genetic regulation of nascent RNA maturation revealed by direct RNA nanopore sequencing

A Deep Dive into Statistical Modeling of RNA Splicing QTLs Reveals New Variants that Explain Neurodegenerative Disease

<scp>RNA</scp> structures in alternative splicing and back‐splicing

Genetic control of alternative splicing and its distinct role in colorectal cancer mechanisms

RNA Structures in Alternative Splicing and Back‐splicing

Supplementary Data from Genome-Wide Splicing Quantitative Expression Locus Analysis Identifies Causal Risk Variants for Non–Small Cell Lung Cancer

The impact of cell type and context-dependent regulatory variants on human immune traits

Deciphering Associations Between Three RNA Splicing-Related Genetic Variants and Lung Cancer Risk

RT‐PCR Analysis of Mrna Revealed the Splice‐altering Effect of Rare Intronic Variants in Monogenic Disorders

Integrating Whole Genome and Transcriptome Sequencing to Characterize the Genetic Architecture of Isoform Variation and its Implications for Health and Disease

Listening to silence and understanding nonsense: exonic mutations that affect splicing

Genetic Variation and Microrna Targeting of A-to-I RNA Editing Fine Tune Human Tissue Transcriptomes.

Effects of genetic variation on the structure of RNA and protein

Environmental influences on RNA processing: Biochemical, molecular and genetic regulators of cellular response